Quest Diagnostics Incorporated (DGX) has a market capitalization of $21.49B and trades at $194.16. The 52-week range is 157.2-213.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 21.9, Earnings Per Share (EPS) of $8.87, annual revenue of $11.04B.
The stock has a beta of 0.65, a last dividend of $3.2000, operates in the Healthcare sector.
